NCT07763496 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07763496
Title	Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer (STELLA)
Acronym	STELLA
Recruitment	Not yet recruiting
Gender	female
Phase	Phase II
Variant Requirements	No
Sponsors	ARCAGY/ GINECO GROUP
Indications	cervical squamous cell carcinoma cervical adenocarcinoma cervical adenosquamous carcinoma
Therapies	Nab-paclitaxel + Relacorilant
Age Groups:	adult \| senior
Covered Countries	FRA

Facility	Status	City	State	Zip	Country	Details
Centre Léon Bérard		Lyon			France	Details
Groupe Hospitalier Diaconesses Croix Saint-Simon		Paris			France	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07763496Clinical Trial Detail